{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:57:34Z","timestamp":1790902654546,"version":"4.1.0"},"reference-count":80,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2005,5]]},"DOI":"10.1016\/j.molimm.2004.07.046","type":"journal-article","created":{"date-parts":[[2004,11,18]],"date-time":"2004-11-18T06:37:05Z","timestamp":1100759825000},"page":"839-848","source":"Crossref","is-referenced-by-count":98,"title":["Therapeutic intravenous immunoglobulins"],"prefix":"10.1016","volume":"42","author":[{"given":"R\u00e9al","family":"Lemieux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9e","family":"Bazin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"N\u00e9ron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molimm.2004.07.046_bib1","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.4049\/jimmunol.145.11.3807","article-title":"IgG autoantibody activity in normal mouse serum is controlled by IgM","volume":"145","author":"Adib","year":"1990","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2004.07.046_bib2","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1046\/j.1537-2995.1997.37497265347.x","article-title":"Monoclonal anti-D is not effective in the treatment of chronic autoimmune thrombocytopenic purpura","volume":"37","author":"Atrah","year":"1997","journal-title":"Transfusion"},{"key":"10.1016\/j.molimm.2004.07.046_bib3","first-page":"103","article-title":"Studies on natural antibodies and autoantibodies","volume":"134D","author":"Avrameas","year":"1983","journal-title":"Ann. Immunol. (Paris)"},{"key":"10.1016\/j.molimm.2004.07.046_bib4","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/0161-5890(93)90160-D","article-title":"The natural autoantibodies system: between hypotheses and facts","volume":"30","author":"Avrameas","year":"1993","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.molimm.2004.07.046_bib5","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1331\/108658002763316888","article-title":"Intravenous immunoglobulins: clinical experience and viral safety","volume":"42","author":"Ballow","year":"2002","journal-title":"J. Am. Pharm. Assoc."},{"key":"10.1016\/j.molimm.2004.07.046_bib6","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1046\/j.1365-3083.2000.00699.x","article-title":"Neutralization of disease associated autoantibodies by an immunoglobulin M- and immunoglobulin A-enriched human intravenous immunoglobulin preparation","volume":"51","author":"Bar-Dayan","year":"2000","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.molimm.2004.07.046_bib7","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1046\/j.1365-3083.1996.d01-36.x","article-title":"Intravenous immunoglobulin (IVIg) modulates the expansion of V beta 3+ and V beta 17+ T cells induced by staphylococcal enterotoxin B superantigen in vitro","volume":"43","author":"Baudet","year":"1996","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.molimm.2004.07.046_bib8","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1182\/blood.V74.7.2414.2414","article-title":"Inhibition of autoantibody binding to platelet glycoprotein IIb\/IIIa by anti-idiotypic antibodies in intravenous gammaglobulin","volume":"74","author":"Berchtold","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.molimm.2004.07.046_bib9","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/0140-6736(93)90563-V","article-title":"Soluble CD4, CD8, and HLA molecules in commercial immunoglobulin preparations","volume":"341","author":"Blasczyk","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.molimm.2004.07.046_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-2776(08)60271-0","article-title":"Natural antibodies and the immune response","volume":"5","author":"Boyden","year":"1966","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.molimm.2004.07.046_bib11","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S1074-7613(03)00080-3","article-title":"Colony-stimulating factor-1-dependent macrophages are responsible for IVIG protection in antibody-induced autoimmune disease","volume":"18","author":"Bruhns","year":"2003","journal-title":"Immunity"},{"key":"10.1016\/j.molimm.2004.07.046_bib12","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1097\/01.LAB.0000077982.70800.02","article-title":"Polyreactive autoantibodies purified from human intravenous immunoglobulins prevent the development of experimental autoimmune diseases","volume":"83","author":"Bruley-Rosset","year":"2003","journal-title":"Lab. Invest."},{"key":"10.1016\/j.molimm.2004.07.046_bib13","doi-asserted-by":"crossref","first-page":"S147","DOI":"10.1016\/0090-1229(89)90080-9","article-title":"The use of intravenous gamma-globulin in idiopathic thrombocytopenic purpura","volume":"53","author":"Bussel","year":"1989","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.molimm.2004.07.046_bib14","first-page":"1","article-title":"Recent advances in the treatment of idiopathic thrombocytopenic purpura: the anti-D clinical experience","volume":"35","author":"Bussel","year":"1998","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.molimm.2004.07.046_bib15","first-page":"883","article-title":"Infusion of a monoclonal anti-FcR III in patients with refractory ITP","volume":"169","author":"Bussel","year":"1990","journal-title":"Neo-Adjuvant Chemother."},{"key":"10.1016\/j.molimm.2004.07.046_bib16","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1056\/NEJM198605083141907","article-title":"Treatment of refractory immune thrombocytopenic purpura with an anti-Fc gamma-receptor antibody","volume":"314","author":"Clarkson","year":"1986","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molimm.2004.07.046_bib17","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1021\/ja01207a034","article-title":"Preparation and properties of serum and plasma proteins","volume":"68","author":"Cohn","year":"1946","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.molimm.2004.07.046_bib18","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/j.1365-2141.2004.04804.x","article-title":"Intravenous (IV) anti-D and IV immunoglobulin achieve acute platelet increases by different mechanisms: modulation of cytokine and platelet responses to IV anti-D by FcgRIIa and FcgRIIIa polymorphisms","volume":"124","author":"Cooper","year":"2004","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.molimm.2004.07.046_bib19","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/0952-7915(95)80053-0","article-title":"Natural autoantibodies","volume":"7","author":"Coutinho","year":"1995","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.molimm.2004.07.046_bib20","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1182\/blood-2003-01-0023","article-title":"IVIg-mediated amelioration of murine ITP via FcgammaRIIB is independent of SHIP1, SHP-1, and Btk activity","volume":"102","author":"Crow","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.molimm.2004.07.046_bib21","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1046\/j.1365-2141.2001.03136.x","article-title":"IVIg inhibits reticuloendothelial system function and ameliorates murine passive-immune thrombocytopenia independent of anti-idiotype reactivity","volume":"115","author":"Crow","year":"2001","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.molimm.2004.07.046_bib22","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1146\/annurev.immunol.15.1.203","article-title":"Fc receptor biology","volume":"15","author":"Daeron","year":"1997","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.molimm.2004.07.046_bib23","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1212\/WNL.59.12_suppl_6.S13","article-title":"Mechanisms of action of IVIg and therapeutic considerations in the treatment of acute and chronic demyelinating neuropathies","volume":"59","author":"Dalakas","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.molimm.2004.07.046_bib24","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1182\/blood-2002-06-1684","article-title":"Intravenous immunoglobulins induce the in vitro differentiation of human B lymphocytes and the secretion of IgG","volume":"101","author":"de Grandmont","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.molimm.2004.07.046_bib25","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1172\/JCI110104","article-title":"Dysfunctions of pokeweed mitogen-stimulated T and B lymphocyte responses induced by gammaglobulin therapy","volume":"67","author":"Durandy","year":"1981","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molimm.2004.07.046_bib26","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0198-8859(00)00250-0","article-title":"Human polyspecific immunoglobulin for therapeutic use induces p21\/WAF-1 and Bcl-2, which may be responsible for G1 arrest and long-term survival","volume":"62","author":"Ekberg","year":"2001","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.molimm.2004.07.046_bib27","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1046\/j.1365-3148.2001.00288.x","article-title":"Intravenous immunoglobulin: regulatory perspectives on use and supply","volume":"11","author":"Farrugia","year":"2001","journal-title":"Transfus. Med."},{"key":"10.1016\/j.molimm.2004.07.046_bib28","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1056\/NEJM198205273062102","article-title":"Transient reversal of thrombocytopenia in idiopathic thrombocytopenic purpura by high-dose intravenous gamma globulin","volume":"306","author":"Fehr","year":"1982","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molimm.2004.07.046_bib29","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1046\/j.1537-2995.1996.36496226146.x","article-title":"Treatment of chronic autoimmune thrombocytopenic purpura with monoclonal anti-D","volume":"36","author":"Godeau","year":"1996","journal-title":"Transfusion"},{"key":"10.1016\/j.molimm.2004.07.046_bib30","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.4049\/jimmunol.128.6.2779","article-title":"Naturally occurring antibodies against nine common antigens in human sera","volume":"128","author":"Guilbert","year":"1982","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2004.07.046_bib31","first-page":"11","article-title":"Intravenous immune globulin use in Canada","volume":"10","author":"Hanna","year":"2003","journal-title":"Can. J. Clin. Pharmacol."},{"key":"10.1016\/j.molimm.2004.07.046_bib32","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1046\/j.1365-2249.2000.01229.x","article-title":"IVIG-bound IgG and IgM cloned by phage display from a healthy individual reveal the same restricted germ-line gene origin as in autoimmune thrombocytopenia","volume":"121","author":"Hoffmann","year":"2000","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.molimm.2004.07.046_bib33","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/eji.1830230402","article-title":"Expression and control of the natural autoreactive IgG repertoire in normal human serum","volume":"23","author":"Hurez","year":"1993","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.molimm.2004.07.046_bib34","doi-asserted-by":"crossref","first-page":"4004","DOI":"10.1182\/blood.V90.10.4004","article-title":"Pooled normal human polyspecific IgM contains neutralizing anti-idiotypes to IgG autoantibodies of autoimmune patients and protects from experimental autoimmune disease","volume":"90","author":"Hurez","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.molimm.2004.07.046_bib35","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/S0140-6736(81)92400-4","article-title":"High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood","volume":"1","author":"Imbach","year":"1981","journal-title":"Lancet"},{"key":"10.1016\/j.molimm.2004.07.046_bib36","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1600-065X.1994.tb00858.x","article-title":"V region-mediated selection of autoreactive repertoires by intravenous immunoglobulin (i.v.Ig)","volume":"139","author":"Kazatchkine","year":"1994","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.molimm.2004.07.046_bib37","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1056\/NEJMra993360","article-title":"Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin","volume":"345","author":"Kazatchkine","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molimm.2004.07.046_bib38","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S0140-6736(05)78212-X","article-title":"Intravenous immunoglobulins and transforming growth factor beta","volume":"351","author":"Kekow","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.molimm.2004.07.046_bib39","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1006\/jaut.1999.0302","article-title":"In vivo administration of intravenous immunoglobulin (IVIg) can lead to enhanced erythrocyte sequestration","volume":"13","author":"Kessary-Shoham","year":"1999","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.molimm.2004.07.046_bib40","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0091-6749(95)70185-0","article-title":"High-dose intravenous gamma-globulin treatment for hyperimmunoglobulinemia E syndrome","volume":"95","author":"Kimata","year":"1995","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.molimm.2004.07.046_bib41","series-title":"IVIG Utilization Management Handbook","article-title":"Adverse reaction to IVIG","author":"Kleinman","year":"2002"},{"key":"10.1016\/j.molimm.2004.07.046_bib42","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1046\/j.1537-2995.2003.00519.x","article-title":"Intravenous immune globulins: an update for clinicians","volume":"43","author":"Knezevic-Maramica","year":"2003","journal-title":"Transfusion"},{"key":"10.1016\/j.molimm.2004.07.046_bib43","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1046\/j.1365-3083.2003.01314.x","article-title":"Natural autoantibodies as tools to predict the outcome of immune response?","volume":"58","author":"Kohler","year":"2003","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.molimm.2004.07.046_bib44","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1212\/WNL.59.12_suppl_6.S22","article-title":"Therapy of CIDP and related immune-mediated neuropathies","volume":"59","author":"Koski","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.molimm.2004.07.046_bib45","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0022-1759(98)00074-X","article-title":"Self-reactive antibodies (natural autoantibodies) in healthy individuals","volume":"216","author":"Lacroix-Desmazes","year":"1998","journal-title":"J. Immunol. Meth."},{"key":"10.1016\/j.molimm.2004.07.046_bib46","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1093\/intimm\/dxh094","article-title":"Autoantibodies purified from therapeutic preparations of intravenous immunoglobulins (IVIg) induce the formation of autoimmune complexes in normal human serum: a role in the in vivo mechanisms of action of IVIg","volume":"16","author":"Lamoureux","year":"2004","journal-title":"Int. Immunol."},{"key":"10.1016\/j.molimm.2004.07.046_bib47","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1473-0502(03)00043-0","article-title":"Mechanism of action of IVIG and anti-D in ITP","volume":"28","author":"Lazarus","year":"2003","journal-title":"Transfus. Apheresis Sci."},{"key":"10.1016\/j.molimm.2004.07.046_bib48","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1046\/j.1423-0410.2003.00285.x","article-title":"Properties of a new intravenous immunoglobulin (IGIV-C, 10%) produced by virus inactivation with caprylate and column chromatography","volume":"84","author":"Lebing","year":"2003","journal-title":"Vox Sang"},{"key":"10.1016\/j.molimm.2004.07.046_bib49","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1006\/clim.2001.5004","article-title":"The B cell superantigen-like interaction of intravenous immunoglobin (IVIG) with Fab fragments of V(H) 3\u201323 and 3\u201330\/3\u201330.5 germline gene origin cloned from a patient with Kawasaki disease is enhanced after IVIG therapy","volume":"99","author":"Leucht","year":"2001","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.molimm.2004.07.046_bib50","first-page":"46","article-title":"In-vitro inhibition of antiplatelet autoantibodies by intravenous immunoglobulins and Rh immunoglobulins","volume":"42","author":"Mehta","year":"1996","journal-title":"J. Postgrad. Med."},{"key":"10.1016\/j.molimm.2004.07.046_bib51","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/0002-9378(90)90025-3","article-title":"Resolution of severe thrombocytopenia in a pregnant patient with rhesus-negative blood with autoimmune thrombocytopenic purpura after intravenous rhesus immune globulin","volume":"162","author":"Moise","year":"1990","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"Suppl. 15","key":"10.1016\/j.molimm.2004.07.046_bib52","first-page":"S53","article-title":"Safety and side effects of i.v. immunoglobulin therapy","volume":"14","author":"Nydegger","year":"1996","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.molimm.2004.07.046_bib53","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1021\/ja01170a048","article-title":"The separation of the antibodies, isoagglutinins, prothrombin, plasminogen and beta-lipoprotein into subfractions of human plasma","volume":"71","author":"Oncley","year":"1949","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.molimm.2004.07.046_bib54","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/383263a0","article-title":"Role of the inositol phosphatase SHIP in negative regulation of the immune system by the receptor Fc\u03b3IIB","volume":"383","author":"Ono","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.molimm.2004.07.046_bib55","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1002\/1529-0131(200012)43:12<2722::AID-ANR12>3.0.CO;2-N","article-title":"Restricted VH3 gene usage in phage-displayed Fab that are selected by intravenous immunoglobulin","volume":"43","author":"Osei","year":"2000","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.molimm.2004.07.046_bib56","series-title":"IVIG Utilization Management Handbook","article-title":"IVIG supply and cost","author":"Pi","year":"2002"},{"key":"10.1016\/j.molimm.2004.07.046_bib57","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.4049\/jimmunol.161.7.3781","article-title":"Therapeutic preparations of normal polyspecific IgG (IVIg) induce apoptosis in human lymphocytes and monocytes: a novel mechanism of action of IVIg involving the Fas apoptotic pathway","volume":"161","author":"Prasad","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2004.07.046_bib58","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.290.5489.84","article-title":"Immune inhibitory receptors","volume":"290","author":"Ravetch","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.molimm.2004.07.046_bib59","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF00320381","article-title":"Treatment of autoimmune thrombocytopenic purpura with Rhesus antibodies (anti-Rho(D))","volume":"49","author":"Salama","year":"1984","journal-title":"Blut"},{"key":"10.1016\/j.molimm.2004.07.046_bib60","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0140-6736(83)90175-7","article-title":"Effect of intravenous immunoglobulin in immune thrombocytopenia","volume":"2","author":"Salama","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.molimm.2004.07.046_bib61","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1126\/science.291.5503.484","article-title":"Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor","volume":"291","author":"Samuelsson","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.molimm.2004.07.046_bib62","series-title":"IVIG Utilization Management Handbook","article-title":"IVIG utilization in British Columbia","author":"Selin","year":"2002"},{"key":"10.1016\/j.molimm.2004.07.046_bib63","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/ajh.10065","article-title":"Anti-D (WinRho SD) treatment of children with chronic autoimmune thrombocytopenic purpura stimulates transient cytokine\/chemokine production","volume":"69","author":"Semple","year":"2002","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.molimm.2004.07.046_bib64","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1046\/j.1365-2567.2002.01545.x","article-title":"Immunomodulatory action of intravenous immunoglobulin","volume":"107","author":"Sewell","year":"2002","journal-title":"Immunology"},{"key":"10.1016\/j.molimm.2004.07.046_bib65","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1034\/j.1398-9995.2003.00239.x","article-title":"IVIG \u2013 mechanisms of action","volume":"58","author":"Simon","year":"2003","journal-title":"Allergy"},{"key":"10.1016\/j.molimm.2004.07.046_bib66","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0091-6749(98)70130-7","article-title":"Intravenous immunoglobulin inhibits IgE production in human B lymphocytes","volume":"102","author":"Sigman","year":"1998","journal-title":"J. Allergy Clin. Immunol."},{"issue":"Suppl. 4","key":"10.1016\/j.molimm.2004.07.046_bib67","doi-asserted-by":"crossref","first-page":"S227","DOI":"10.1007\/s10072-003-0083-5","article-title":"Treatment of multiple sclerosis with intravenous immunoglobulin: review of clinical trials","volume":"24","author":"Sorensen","year":"2003","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.molimm.2004.07.046_bib68","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1182\/blood.V95.1.328","article-title":"Altered control of self-reactive IgG by autologous IgM in patients with warm autoimmune hemolytic anemia","volume":"95","author":"Stahl","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.molimm.2004.07.046_bib69","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0896-8411(91)90028-B","article-title":"Stimulation of B and T cells by in vivo high dose immunoglobulin administration in normal mice","volume":"4","author":"Sundblad","year":"1991","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.molimm.2004.07.046_bib70","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1002\/eji.1830210510","article-title":"Normal serum immunoglobulins influence the numbers of bone marrow pre-B and B cells","volume":"21","author":"Sundblad","year":"1991","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.molimm.2004.07.046_bib71","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1600-065X.1994.tb00860.x","article-title":"Observations on the mode of action of normal immunoglobulin at high doses","volume":"139","author":"Sundblad","year":"1994","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.molimm.2004.07.046_bib72","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1182\/blood.V98.4.1095","article-title":"Therapeutic efficacy of intravenous immunoglobulin preparations depends on the immunoglobulin G dimers: studies in experimental immune thrombocytopenia","volume":"98","author":"Teeling","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.molimm.2004.07.046_bib73","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/jlb.67.1.2","article-title":"CD40\u2013CD40 ligand","volume":"67","author":"van Kooten","year":"2000","journal-title":"J. Leukocyte Biol."},{"key":"10.1016\/j.molimm.2004.07.046_bib74","first-page":"165","article-title":"Use of anti-D (Rh) IgG or intramuscular polyvalent human immunoglobulin in the treatment of chronic autoimmune thrombocytopenic purpura","volume":"33","author":"Vizcaino","year":"1992","journal-title":"Invest. Clin."},{"key":"10.1016\/j.molimm.2004.07.046_bib75","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s002620050416","article-title":"Fc gamma RI blockade and modulation for immunotherapy","volume":"45","author":"Wallace","year":"1997","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.molimm.2004.07.046_bib76","first-page":"1149","article-title":"The challenge of an increasingly expensive blood system","volume":"168","author":"Wilson","year":"2003","journal-title":"Can. Med. Assoc. J."},{"key":"10.1016\/j.molimm.2004.07.046_bib77","first-page":"377","article-title":"Idiotypic\/antiidiotypic interactions in systemic lupus erythematosus: demonstration of oscillating levels of anti-DNA autoantibodies and reciprocal antiidiotypic activity in a single patient","volume":"134C","author":"Zouali","year":"1983","journal-title":"Ann. Immunol. (Paris)"},{"key":"10.1016\/j.molimm.2004.07.046_bib78","doi-asserted-by":"crossref","first-page":"190","DOI":"10.4049\/jimmunol.133.1.190","article-title":"A human monoclonal IgG1 with anti-idiotypic activity against anti-human thyroglobulin autoantibody","volume":"133","author":"Zouali","year":"1984","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2004.07.046_bib79","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1067\/mai.2002.127284","article-title":"Suppression of IL-4- and CD40- induced B-lymphocyte activation by intravenous immunoglobulin is not mediated through the inhibitory IgG receptor FcgammaRIIb","volume":"110","author":"Zhuang","year":"2002","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.molimm.2004.07.046_bib80","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1067\/mai.2001.116291","article-title":"Inhibition of IgE production in vitro by intact and fragmented intravenous immunoglobulin","volume":"108","author":"Zhuang","year":"2001","journal-title":"J. Allergy Clin. Immunol."}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589004004055?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589004004055?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,30]],"date-time":"2023-04-30T09:24:09Z","timestamp":1682846649000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161589004004055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5]]},"references-count":80,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2005,5]]}},"alternative-id":["S0161589004004055"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2004.07.046","relation":{},"ISSN":["0161-5890"],"issn-type":[{"value":"0161-5890","type":"print"}],"subject":[],"published":{"date-parts":[[2005,5]]}}}